国内化学药品95%以上为仿制药8月18日,《国务院关于改革药品医疗器械审评审批制度的意见》(下称《意见》)发布,将提高仿制药质量列为改革主要目标之一,提出加快仿制药质量一致性评价,力争2018年底前完成国家基本药物口服制剂与参比制剂质量一致性评价。对此,一位不愿意具名的国家食品药品监督管理总局(下称“食药监总局”)相关人士对《中国经济周刊》 More than 95% of domestic chemicals are generic drugs On August 18, the “Opinions of the State Council on Reforming and Reviewing the Examination and Approval System for Medical Devices and Medical Devices” (the “Opinions”) was released. As one of the major objectives of the reform, improving the quality of generic drugs, Proposed to speed up the consistency of generic drug quality evaluation, and strive to complete by the end of 2018 the consistency of the national essential medicines oral formulations and reference preparations quality evaluation. In response, an unnamed State Food and Drug Administration (hereinafter referred to as “Food and Drug Administration”) stakeholders on the “China Economic Weekly”